Dr. Mark Socinski graduated medical school from University of Vermont College of Medicine and completed his residency program at Beth Israel Deaconess Medical Center. A fellowship in medical oncology followed at the Dana-Farber Cancer Institute. Dr. Socinski is specialized in oncology and board certified in internal medicine and medical oncology. He has been in practice for more than 20 years and is a member of several medical organizations, including the American College of Chest Physicians and also the American Society of Clinical Oncology.
University of Vermont College of Medicine Graduated in 1984
Beth Israel Deaconess Medical Center Completed in 1986
Dana-Farber Cancer Institute Completed in 1989
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitu.
Paz-Ares, L.,Socinski, M. A.,Shahidi, J.,Hozak, R. R.,Soldatenkova, V.,Kurek, R.,Varella-Garcia, M.,Thatcher, N.,Hirsch, F. R.; Ann. Oncol.. 2016 May 22See more >>
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes
Villaruz, L. C.,Socinski, M. A.; Eur. J. Cancer. 2016 Feb 15See more >>
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
Shaw, A. T.,Gandhi, L.,Gadgeel, S.,Riely, G. J.,Cetnar, J.,West, H.,Camidge, D. R.,Socinski, M. A.,Chiappori, A.,Mekhail, T.,Chao, B. H.,Borghaei, H.,Gold, K. A.,Zeait...; Lancet Oncol.. 2015 Dec 29.See more >>
American College of Chest Physicians
American College of Physicians
American Society of Clinical Oncology
International Association for the Study of Lung Cancer